EPRS has previously been shown to regulate transcript-specific translation in macrophages and hepatocellular carcinoma cells through the gamma interferon-activated inhibitor of translation (GAIT) system [6, 7, 17, 28–33]. The gene discussed is IFNG; the disease is hepatocellular carcinoma.